SLDB
Conviction 47HealthcareScan · Thu, Sep 24, 2026Solid Biosciences Inc. (SLDB) closed at $7.48 (-6.73%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 34, RS Rating 75, -32.9% from its 52-week high, +37.3% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
Financials as of Thu, Sep 30, 2021 · quarterly.
Congress activity
Disclosed STOCK Act trades in SLDB
Insider activity
SEC Form 4 transactions in SLDB
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SMITH IAN F Director · Common Stock · 2026-07-02 | Exercise | 3.44K | — | 2026-07-02 | 2026-07-07 |
SMITH IAN F Director · Restricted Stock Units · 2026-07-02 | Exercise | 3.44K | — | 2026-07-02 | 2026-07-07 |
Tan Kevin CFO & Treasurer · Restricted Stock Units · 2026-01-29 | Grant | 56.65K | $0 | 2026-01-29 | 2026-04-21 |
Howton David T Chief Operating Officer · Restricted Stock Units · 2026-01-29 | Grant | 79.34K | $0 | 2026-01-29 | 2026-04-21 |
Brooks Gabriel Chief Medical Officer · Restricted Stock Units · 2026-01-29 | Grant | 58.85K | $0 | 2026-01-29 | 2026-04-21 |
Hanrahan Jessie Chief Regulatory Officer · Restricted Stock Units · 2026-01-29 | Grant | 54.92K | $0 | 2026-01-29 | 2026-04-21 |
Cumbo Alexander President and CEO · Restricted Stock Units · 2026-01-29 | Grant | 169.4K | $0 | 2026-01-29 | 2026-04-21 |
Herzich Paul Chief Technology Officer · Restricted Stock Units · 2026-01-29 | Grant | 54.92K | $0 | 2026-01-29 | 2026-04-21 |
SEC filings
EDGAR filings in SLDB · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.